Combined aberrant expression of E-cadherin and S100A4, but not β-catenin is associated with disease-free survival and overall survival in colorectal cancer patients
about
S100A4 in Cancer Metastasis: Wnt Signaling-Driven Interventions for Metastasis RestrictionImpact of S100A4 Expression on Clinicopathological Characteristics and Prognosis in Pancreatic Cancer: A Meta-AnalysisAlterations of the apical junctional complex and actin cytoskeleton and their role in colorectal cancer progressionEpigenetic silencing of miR-520c leads to induced S100A4 expression and its mediated colorectal cancer progressionClinicopathological and prognostic significance of S100A4 overexpression in colorectal cancer: a meta-analysis.Relationship between osteopontin and β-catenin immunohistochemical expression and prognostic parameters of colorectal carcinoma.Prognostic Significance of Nuclear β-Catenin Expression in Patients with Colorectal Cancer from Iran.S100A4 drives non-small cell lung cancer invasion, associates with poor prognosis, and is effectively targeted by the FDA-approved anti-helminthic agent niclosamideNuclear expression and/or reduced membranous expression of β-catenin correlate with poor prognosis in colorectal carcinoma: A meta-analysis.Gene of the month: E-cadherin (CDH1).Prognostic value of perineural invasion in colorectal cancer: a meta-analysis.Activation of the PI3K/Akt/mTOR/p70S6K pathway is involved in S100A4-induced viability and migration in colorectal cancer cells.Gene silencing of NOB1 by lentivirus suppresses growth and migration of human osteosarcoma cells.Vascular Invasion and Stromal S100A4 Expression at the Invasive Front of Colorectal Cancer are Novel Determinants and Tumor Prognostic Markers.Differential β-catenin expression levels are associated with morphological features and prognosis of colorectal cancer.Gland Attenuation, a Novel Morphological Feature of Colorectal Cancer: Evidence for an Epithelial-Mesenchymal Transition
P2860
Q26743403-5D890BE9-4A51-4B3F-9F06-0AFDD5C96CBDQ26768261-F66787CB-BF96-4355-80AC-CD2A3404EC3CQ26785540-A45002C2-6C15-4C93-BF0B-1FBFEA3144A8Q33591453-61003C7F-3E05-48B4-A4D9-9508D96E61B8Q35031420-E09BB89A-3C8F-42C7-9CC5-31C1382C2522Q35406491-8992D651-A01A-412B-AF26-2992B4D29986Q36095799-9BBC2247-E2C1-4EA8-BC64-B00324CB68A0Q37376360-E8A283E2-A30E-4F80-B3DC-89B0DD18C943Q37606108-54363A2D-3841-4C40-BD6D-DD4D48209C5CQ38128549-86950BC5-DEC6-46A7-9883-B0DE87323D8CQ38348686-E305103A-BBBE-4982-BFBB-CBA9DE8AF15CQ38983986-66472EBA-9508-4E24-8ED1-ACF298AA92B8Q39006127-B56FAFD5-9626-4AE9-B9B4-E2785B27B2A0Q41180159-F7C53C15-EBFE-4124-8257-7597FBE7CE7FQ42931039-8ABD4F2F-B72E-49E4-A454-CE3C539E4038Q58779870-E7EA0976-CA70-4798-98A3-341E1CFD7DF0
P2860
Combined aberrant expression of E-cadherin and S100A4, but not β-catenin is associated with disease-free survival and overall survival in colorectal cancer patients
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Combined aberrant expression o ...... in colorectal cancer patients
@en
Combined aberrant expression o ...... in colorectal cancer patients.
@nl
type
label
Combined aberrant expression o ...... in colorectal cancer patients
@en
Combined aberrant expression o ...... in colorectal cancer patients.
@nl
prefLabel
Combined aberrant expression o ...... in colorectal cancer patients
@en
Combined aberrant expression o ...... in colorectal cancer patients.
@nl
P2093
P2860
P356
P1433
P1476
Combined aberrant expression o ...... in colorectal cancer patients
@en
P2093
Eun Jeoung Lee
Meiying Ji
Rohyun Sung
Sang-Jeon Lee
Sei Jin Youn
Seon Mee Park
Song Yi Choi
Soon Man Yoon
Taek-Gu Lee
P2860
P2888
P356
10.1186/1746-1596-8-99
P577
2013-06-19T00:00:00Z
P5875
P6179
1045585324